Warning: mkdir(): No space left on device in /www/wwwroot/zhenghe1718.com/func.php on line 127

Warning: file_put_contents(./cachefile_yuan/99dujia.com/cache/f8/419de/c43a5.html): failed to open stream: No such file or directory in /www/wwwroot/zhenghe1718.com/func.php on line 115
Anti-COL1A2 (S3) Antibody |产品详情|进口榴莲视频免费观看采购网





    榴莲视频下载地址入口,8008APP幸福宝榴莲,榴莲视频免费观看,榴莲视频污污污下载

    订购信息
    上海榴莲视频下载地址入口生物科技公司
    Tel:400-968-7988    021-33779008
    Anti-COL1A2 (S3) Antibody
    品牌:Antibodies
    货号:
    规格:50µl
    货期:

    Anti-COL1A2 (S3) Antibody

    商品详情 参考文献 相关资料
    Name: Anti-COL1A2 (S3) Antibody
    See all COL1A2 primary antibodies
    Description: Rabbit polyclonal antibody to COL1A2 (S3)
    Specificity: COL1A2 (S3) pAb detects endogenous levels of Collagen alpha-2(I) chain protein.
    Applications: WB, IHC, IF
    Reactivity: Human, Mouse, Rat
    Immunogen: Synthetic peptide, corresponding to the N-terminus of Human COL1A2.
    Host: Rabbit
    Clonality: Polyclonal
    Conjugate: Unconjugated
    Molecular Weight: ~ 125 kDa
    Purity: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
    Product Form: 1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.2.
    Function: Type I collagen is a member of group I collagen (fibrillar forming collagen).
    Tissue Specificity: Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.
    Involvement in Disease: Ehlers-Danlos syndrome 7B: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocations, hyperlaxity of the joints, and recurrent partial dislocationss.

    Osteogenesis imperfecta 1: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta.

    Osteogenesis imperfecta 2: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency.

    Ehlers-Danlos syndrome, autosomal recessive, cardiac valvular form: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, patients have mitral valve prolapse and insufficiency, mitral regurgitation, and aortic insufficiency.

    Osteogenesis imperfecta 3: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosesis, grayish sclera and dentinogenesis imperfecta.

    Osteogenesis imperfecta 4: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosesis, grayish or white sclera and dentinogenesis imperfecta.
    Sequence Similarities: Belongs to the fibrillar collagen family.
    Post-Translational Modification: Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.
    Cellular locations: Secreted > Extracellular space > Extracellular matrix.
    Database Links:
  1. Entrez Gene: 1278?Human
  2. Entrez Gene: 12843?Mouse
  3. Entrez Gene: 84352?Rat
  4. Omim: 120160?Human
  5. SwissProt: P08123?Human
  6. SwissProt: Q01149?Mouse
  7. SwissProt: P02466?Rat
  8. Unigene: 489142?Human
  9. Unigene: 277792?Mouse
  10. Unigene: 107239?Rat
  11. Synonyms:
  12. Alpha 2 collagen type I Antibody
  13. Alpha 2 type I collagen Antibody
  14. Alpha 2 type I procollagen Antibody
  15. Alpha 2(I) collagen Antibody
  16. Alpha 2(I) procollagen Antibody
  17. Alpha-2 type I collagen Antibody
  18. CO1A2_HUMAN Antibody
  19. COL1A2 Antibody
  20. Collagen alpha 2(I) chain Antibody
  21. Collagen alpha-2(I) chain Antibody
  22. Collagen I alpha 2 polypeptide Antibody
  23. Collagen of skin tendon and bone alpha 2 chain Antibody
  24. Collagen type I alpha 2 Antibody
  25. OI4 Antibody
  26. Osteogenesis imperfecta type IV Antibody
  27. Type I procollagen Antibody
  28. Information: Target information shown above is from the UniProt Consortium.
    • 关于榴莲视频下载地址入口
    • 购物流程
    • 支付方式
    • 配送方式
    Copyright@ 2003-2026  进口榴莲视频免费观看采购网版权所有     

    BIOLEAF热搜   BIOLEAF8008APP幸福宝榴莲   BIOLEAF ELISA   BIOLEAF榴莲视频免费观看   BIOLEAF品牌   BIOLEAF抗体   BIOLEAF耗材   BIOLEAF小仪器

    sitemap   细胞库查询   危险品图标

    本公司网站所展示销售的产品仅供科研!

             沪ICP备08023583号-6     
    产品咨询
    QQ扫码沟通
    在线客服
    服务电话
    400-968-7988
    扫码关注
    微信公众号二维码

    沪公网安备 31011202007338号

    网站地图